A sneak preview of four studies to be presented at the upcoming ASCO GI (American Society of Oncology Gastrointestinal cancer) meeting in San Francisco (January 20-22) shows that the era of personalized medicine has arrived. The studies, respectively, focused on intensity –modulated radiation therapy (IMRT) as a safer alternative to conventional radiotherapy for the treatment [...]
By Nancy Ciancaglini As is the case every year at ASCO, in spite of 4,000 plus studies generated in time for the meeting there are a handful of clinical news stories that really stand-out and grab the attention of researchers, MDs, analysts/investors, and the media. Below, OBR presents a quick overview of what we consider [...]
OBR green is our dynamic, eco-friendly companion to our print journal Oncology Business Review. Register to begin receiving OBR green today. View the Most Recent Issue»
